Skip to main content
Cameron Callaghan, MD, Radiation Oncology, Rochester, MN

CameronCallaghanMDMPH MS(He/Him)

Radiation Oncology Rochester, MN

Gastrointestinal Cancer

Associate Consultant

Dr. Callaghan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Callaghan's full profile

Already have an account?

  • Office

    200 1st St SW
    Rochester, MN 55905
    Phone+1 507-284-2511

Education & Training

  • University of Iowa Hospitals and Clinics
    University of Iowa Hospitals and ClinicsResidency, Radiation Oncology, 2018 - 2022
  • University of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola)
    University of Central Florida/HCA Florida Healthcare (Greater Orlando/Osceola)Internship, Transitional Year, 2017 - 2018
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 2017, MD
  • Tulane School of Public Health and Tropical Medicine
    Tulane School of Public Health and Tropical MedicineMPH, 2013 - 2016
  • Tulane School of Medicine
    Tulane School of MedicineMS, Clinical Anatomy, 2013 - 2016

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 2022 - 2025
  • WI State Medical License
    WI State Medical License 2023 - 2025
  • IA State Medical License
    IA State Medical License 2018 - 2022
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Annual Meeting Abstract Travel Award in Biology ASTRO, 2021
  • Oral Presentation ASTRO 2021 Conference ASTRO, 2021
  • Holman Research Pathway in Radiation Oncology ABR, 2019-2021
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Pharmacologic Ascorbate Enhances the Therapeutic Index of ATM-Inhibitor Based Chemoradiation for Colorectal Cancer.
    Callaghan CM, Abukhiran I, VanRheeden R., Ali MY, Petronek MS, Mapuskar KA, Seyedin SN, Kalen AL, Rodman S, Cullen JJ, Coleman M, Goswami P, Buatti JM, Spitz DR, Allen..., Oral presentation. ASTRO 63rd Annual Conference., 10/26/2021
  • Pharmacologic ascorbate enhances the therapeutic index of ATM-inhibitor based chemoradiation for colorectal cancer.
    Callaghan CM, Seyedin SN, Mapuskar KA, Petronek MS, VanRheeden RV, Rodman SN, Cullen JJ, Darbro BW, Spitz DR, Allen BG, Coleman MC, Goswami P, and Caster JM., ASCO 2021, 6/4/2021
  • Utilizing Pharmacologic Ascorbate to Enhance the Therapeutic Index of DNA Repair Inhibitor-Based Chemoradiotherapy for Rectal Cancers.
    Callaghan CM, Seyedin SN, Mapuskar KA, Petronek MS, VanRheeden RV, Rodman SN, Cullen JJ, Darbro BW, Spitz DR, Allen BG, Coleman MC, Goswami P, and Caster JM., ASTRO 2020, 10/25/2020
  • Join now to see all

Lectures

  • Pharmacologic Ascorbate Enhances the Therapeutic Index of ATM-Inhibitor Based Chemoradiation for Colorectal Cancer 
    Oral presentation ASTRO 63rd Annual Conference - 10/26/2021
  • Updates in Diagnosis-specific Graded Prognostic Assessments for Brain Metastases. 
    ISTRO 2019 - 10/26/2019
  • Systematic review of intensity-modulated brachytherapy (IMBT): static and dynamic techniques 
    ABS Annual Conference 2019 Miami, FL. - 3/16/2019

Grant Support

  • Pharmacologic Ascorbate, DNA Repair Inhibitors, and Therapeutic Index of Radiation Therapy in Colorectal CancerRSNA2019–2020

Research History

  • Holman Pathway in Radiation Oncology2019 - 2021

Professional Memberships